XML 39 R5.htm IDEA: XBRL DOCUMENT v2.4.0.6
CONSOLIDATED STATEMENTS OF CHANGES IN STOCKHOLDERS' EQUITY (DEFICIT) (USD $)
Total
Common Stock, Par Value
Additional Paid in Capital
Deficit Accumulated during the Development Stage
Balance at Nov. 15, 2005        
Increase (Decrease) in Stockholders' Equity        
Sale of unregistered common stock to founder $ 2,000 $ 7,569 $ (5,569)  
Sale of unregistered common stock to founder (in shares)   75,690,608    
Sale of common stock 18,100 685 17,415  
Sale of common stock (in shares)   6,850,000    
Net loss for the period (16)     (16)
Balance at Dec. 31, 2005 20,084 8,254 11,846 (16)
Balance (in shares) at Dec. 31, 2005   82,540,608    
Increase (Decrease) in Stockholders' Equity        
Net loss for the period (20,202)     (20,202)
Balance at Dec. 31, 2006 (118) 8,254 11,846 (20,218)
Balance (in shares) at Dec. 31, 2006   82,540,608    
Increase (Decrease) in Stockholders' Equity        
Capital contribution by shareholders 8,893   8,893  
Net loss for the period (20,043)     (20,043)
Balance at Dec. 31, 2007 (11,268) 8,254 20,739 (40,261)
Balance (in shares) at Dec. 31, 2007   82,540,608    
Increase (Decrease) in Stockholders' Equity        
Cancellation of unregistered founder shares   (7,499) 7,499  
Cancellation of unregistered founder shares (in shares)   (74,990,604)    
Common stock issued via Exchange Transaction 27,278,861 2,273 27,276,588  
Common stock issued via Exchange Transaction (in shares)   22,732,380    
Common stock issued via private placements 3,025,000 252 3,024,748  
Common stock issued via private placements (in shares)   2,520,833    
Fees and expenses related to private placements (73,088)   (73,088)  
Stock based compensation expense 379,883   379,883  
Net loss for the period (31,755,180)     (31,755,180)
Balance at Dec. 31, 2008 (1,155,792) 3,280 30,636,369 (31,795,441)
Balance (in shares) at Dec. 31, 2008   32,803,217    
Increase (Decrease) in Stockholders' Equity        
Common stock issued via private placements 15,970,100 1,141 15,968,959  
Common stock issued via private placements (in shares)   11,407,213    
Fees and expenses related to private placements (260,002)   (260,002)  
Common stock Issued for services rendered 1,500 1 1,499  
Common stock Issued for services rendered (in shares)   1,250    
Stock based compensation expense 1,053,062   1,053,062  
Net loss for the period (8,125,100)     (8,125,100)
Balance at Dec. 31, 2009 7,483,768 4,422 47,399,887 (39,920,541)
Balance (in shares) at Dec. 31, 2009   44,211,680    
Increase (Decrease) in Stockholders' Equity        
Common stock issued via registered direct offering and private placement 7,179,000 121 7,178,879  
Common stock issued via registered direct offering and private placement (in shares)   1,209,000    
Fees and expenses related to direct offering (468,130)   (468,130)  
Warrants classified to derivative liability - net (3,784,743)   (3,784,743)  
Common stock issued to extend lock-up agreements related to unregistered shares   67 (67)  
Common stock issued to extend lock-up agreements related to unregistered shares (in shares)   670,933    
Common stock Issued for services rendered 18,271   18,271  
Common stock Issued for services rendered (in shares)   2,469    
Stock based compensation expense 693,887   693,887  
Net loss for the period (15,221,441)     (15,221,441)
Balance at Dec. 31, 2010 (4,099,388) 4,610 51,037,984 (55,141,982)
Balance (in shares) at Dec. 31, 2010   46,094,082    
Increase (Decrease) in Stockholders' Equity        
Common stock issued via registered direct offering and private placement 34,369,064 773 34,368,291  
Common stock issued via registered direct offering and private placement (in shares)   7,733,093    
Fees and expenses related to financing transactions - paid in cash (2,148,383)   (2,148,383)  
Fees and expenses related to financing transactions - paid in units of common stock and warrants   8 (8)  
Fees and expenses related to financing transactions - paid in units of common stock and warrants (in shares)   77,750    
Warrants classified to derivative liability - net (5,094,186)   (5,094,186)  
Common stock issued to make whole certain unregistered shares   22 (22)  
Common stock issued to make whole certain unregistered shares (in shares)   215,981    
Exercise of warrant 415,309 8 415,301  
Exercise of warrant (in shares)   80,000    
Common stock Issued for services rendered 341,295 8 341,287  
Common stock Issued for services rendered (in shares)   79,000    
Stock based compensation expense 480,751   480,751  
Net loss for the period (14,467,036)     (14,467,036)
Balance at Dec. 31, 2011 $ 9,797,426 $ 5,429 $ 79,401,015 $ (69,609,018)
Balance (in shares) at Dec. 31, 2011   54,279,906